This year in summary (estimated) and beyond
Results for 1204 Canine study around Mid June 2022
Results for 1801 Antimicrobial Phase 2b around Mid July 2022
Results for 1702 Rosacea Phase 1b Around Mid September 2022
If results would mean further studies then:
Phase 2 1204 study to start Q3, not sure about this one - Results maybe end of 2022, early 2023?
Phase 3 1801 study to start Q4 2022, go for 12 months, results late 2023
Phase 3 1702 to start end of 2022/start of 2023 to go for 12 months, results late 2023, early 2024
Phase 3 1503 study to start early 2023 to go for 12 months, results early 2024
Permetrex commercial opportunities could be anytime and the other opportunities they have been mentioning lately
BOT - Anything but charting, page-3076
-
- There are more pages in this discussion • 6,621 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 36.5¢ | $2.548M | 6.766M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 96148 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 782479 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |